EMA guideline: no way...: [Design Issues]

posted by wienui  – Germany/Oman, 2019-12-09 06:25 (1156 d 09:54 ago) – Posting: # 20963
Views: 5,269

Dear Mittyri,

❝ I doubt that something exists at the moment.

❝ Please also see the related discussion and cites of EMA guideline.

Thank you very much, it is really helpful.

Best regards,



Complete thread:

UA Flag
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
27 visitors (0 registered, 27 guests [including 9 identified bots]).
Forum time: 16:20 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz